Skip to main content
Clinical Trials/NCT03212872
NCT03212872UnknownNot Applicable

Evaluation of Blood Ammonia Level as a Non Invasive Predictor for Presence of Gastroesophageal Varices and Risk of Bleeding

Tanta University1 site in 1 country150 target enrollmentStarted: July 7, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
150
Locations
1
Primary Endpoint
level of serum ammonia in patients with risk factors for bleeding from esophageal varices

Study Overview

Brief Summary

Assessment of blood ammonia level as a non-invasive predictor for presence of EV and risk of bleeding

Detailed Description

A prospective cross sectional study on 150 consecutive patients screening for esophageal varices.

Patient groups groups:

Group (1): 100 patients with esophageal varices

Group (2): 50 chronic liver disease patients with no esophageal varices as a control group.

All patients will be subjected to:

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients with chronic liver disease

Exclusion Criteria

  • •Patient in hepatic encephalopathy or coma.
  • •Patient in active bleeding or with history of bleeding within the two weeks prior to entry in the study .
  • •Patients with heart failure.
  • •Patients with renal failure.
  • •Patient with hepatocellular carcinoma and portal vein thrombosis.
  • •Patient taking Beta blockers.

Arms & Interventions

Endoscopy

Other

Intervention: Endoscopy (Diagnostic Test)

Outcomes

Primary Outcomes

level of serum ammonia in patients with risk factors for bleeding from esophageal varices

Time Frame: 24 months

estimation of level of serum ammonia in patients with risk factors for bleeding from esophageal varices

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ferial El-Kalla

Professor

Tanta University

Study Sites (1)

Loading locations...

Similar Trials